Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1999;30:2272-2276

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, Y.
Right arrow Articles by Sakurai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, Y.
Right arrow Articles by Sakurai, Y.

(Stroke. 1999;30:2272-2276.)
© 1999 American Heart Association, Inc.


Original Contributions

Clinical Course, Surgical Management, and Long-Term Outcome of Moyamoya Patients With Rebleeding After an Episode of Intracerebral Hemorrhage

An Extensive Follow-Up Study

Yasuko Yoshida, MD, PhD; Takashi Yoshimoto, MD, PhD; Reizo Shirane, MD, PhD Yoshiharu Sakurai, MD, PhD

From the Department of Neurosurgery, Tohoku University School of Medicine (Y.Y., T.Y., R.S.), and the Neurosurgical Department, Stroke Center, Sendai National Hospital (Y.S.), Sendai, Japan.

Background and Purpose—Revascularization surgery for moyamoya patients is believed to prevent cerebral ischemic attacks by improving cerebral blood flow. However, measures preventing the occurrence of hemorrhagic moyamoya in patients have not yet been established in the literature due to the low rate of hemorrhage onset as well as the originally limited numbers of patients with moyamoya disease, poor understanding of the clinical course of rebleeding, correct surgical management, and long-term outcome. We present here the results of an overall survey of patients with hemorrhagic moyamoya disease in a district of Miyagi Prefecture in Japan and examine their clinical course, efficacy of revascularization surgery, and long-term outcome.

Methods—This study included 28 moyamoya patients with episodes of intracranial hemorrhage between 1976 and 1988. The mean follow-up period was 14.2 years. There were 4 males and 24 females, aged 7 to 69 years (mean 39.2 years). Cerebral angiography and CT scans were performed for all patients. Surgical treatment was performed in 19 patients (67.9%), and 10 patients (35.7%) underwent revascularization surgery. We observed the clinical course of all 28 patients. We also studied the relationship between the efficacy of surgical treatment and long-term outcome.

Results—Five of the 28 patients (17.9%) died of the initial intracranial hemorrhage, and 2 patients died of other causes. Rebleeding occurred in 6 of the remaining 21 patients (28.6%). The interval to rebleeding ranged from 2 to 20 years (mean 7.3 years). Of these 6 patients, 4 died of rebleeding. Rebleeding was observed in 1 of 8 patients who underwent bypass surgery and in 5 of 13 patients who did not, which suggested that rebleeding was less likely to occur in patients who had undergone bypass surgery. However, there was no significant difference in rebleeding ratio or mortality between patients with and those without revascularization surgery (P>0.05).

Conclusions—In this study, we compiled the results of meticulous follow-up conducted over the past 10 years for patients with hemorrhagic moyamoya disease. Because hemorrhagic moyamoya disease is known for its high rate of mortality at the time of rebleeding and often causes rebleeding long after the initial episode (as much as 20 years later), implementation of long-term preventive measures for rebleeding is necessary. This suggests that a long-term prospective study of a large number of patients with hemorrhagic moyamoya disease is required to determine whether bypass surgery prevents rebleeding of hemorrhagic moyamoya disease.


Key Words: cerebral revascularization • intracerebral hemorrhage • moyamoya disease




This article has been cited by other articles:


Home page
LupusHome page
H. Jeong, Y. Kim, W Yoon, S. Joo, S. Lee, and Y. Park
Moyamoya syndrome associated with systemic lupus erythematosus
Lupus, July 1, 2008; 17(7): 679 - 682.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
D.M. Walz, R.F. Woldenberg, and A. Setton
Pseudoaneurysm of the Anterior Spinal Artery in a Patient with Moyamoya: An Unusual Cause of Subarachnoid Hemorrhage
AJNR Am. J. Neuroradiol., August 1, 2006; 27(7): 1576 - 1578.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
C. J. Koebbe and M. B. Horowitz
A Rare Case of a Ruptured Middle Meningeal Aneurysm Causing Intracerebral Hematoma in a Patient with Moyamoya Disease
AJNR Am. J. Neuroradiol., April 1, 2004; 25(4): 574 - 576.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Morioka, J.-I. Hamada, T. Kawano, T. Todaka, S. Yano, Y. Kai, and Y. Ushio
Angiographic Dilatation and Branch Extension of the Anterior Choroidal and Posterior Communicating Arteries Are Predictors of Hemorrhage in Adult Moyamoya Patients
Stroke, January 1, 2003; 34(1): 90 - 95.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
K M El Ramahi and H M Al Rayes
Systemic lupus erythematosus associated with moyamoya syndrome
Lupus, October 1, 2000; 9(8): 632 - 636.
[Abstract] [PDF]